Falcon Point Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
CCA
1WCM
Falcon Point Capital's RGEN Position: Q3 2019 in Review
Falcon Point Capital sold out of Repligen (RGEN) in Q3 2019, closing a stake of 6,820 shares — an estimated $586K sold.
Falcon Point Capital first reported a position in RGEN in Q2 2013 and held it in 25 quarters. The position peaked at $1.66M in Q2 2017. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.
- Falcon Point Capital reported no remaining Repligen position as of Q3 2019 after selling out during the quarter.
- Falcon Point Capital sold 6,820 Repligen shares in Q3 2019, an estimated $586K.
- Falcon Point Capital first reported a position in Repligen in Q2 2013 and held it in 25 quarters.
- Falcon Point Capital's Repligen position peaked at $1.66M in Q2 2017.
- 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.
Based on Falcon Point Capital's 13F filing for Q3 2019, filed 13 Nov 2019.